Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney

Australian and New Zealand Journal of Public Health

Volumn 36, Issue 4, 2012, Pages 351-356

  White, Bethany ^a,b   Dore, Gregory J ^a   Lloyd, Andrew ^c   Rawlinson, William ^d   Maher, Lisa ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Hepatitis B virus; Hepatitis C virus; Immunisation; Injecting drug use; Prospective observational study

Indexed keywords

EID: 84864540998     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2012.00881.x     Document Type: Article

References (48)

1. Cowie B, Karapanagiotidis T, Enriquez A, et al. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health. 2010;34(1):72-8.
2. O'Sullivan BG, Gidding HF, Law M, et al. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004;28(3):212-6. (Pubitemid 38868314)
3. Amin J, O'Connell D, Bartlett M, et al. Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study. Aust N Z J Public Health. 2007;31(5):475-82. (Pubitemid 47629025)
4. Amin J, Law MG, Bartlett M, et al. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368(9539):938-45. (Pubitemid 44331386)
5. Custer B, Sullivan SD, Hazlet TK, et al. Global Epidemiology of Hepatitis B Virus. J Clin Gastroenterol. 2004;38(10):S158-S68.
6. Cowie B. The linguistic demography of Australians living with chronic hepatitis B. Aust N Z J Public Health. 2010;35(1):12-5.
7. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Sydney (AUST): The Kirby Institute for Infection and Immunity in Society, University of New South Wales; 2010.
8. Day C, White B, Ross J, et al. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney [Letter]. Aust N Z J Public Health. 2003;27(5):558. (Pubitemid 37287692)
9. Maher L. Hepatitis B vaccination and injecting drug use: narrowing the efficacyeffectiveness gap. Int J Drug Policy. 2008;19(6):425-8.
10. Day CA, White B, Dore GJ, et al. Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status. Drug Alcohol Depend. 2010;108(1-2):134-7.
11. Ramasamy P, Lintzeris N, Sutton Y, et al. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction. 2010;105(2):329-34.
12. Miller ER, Hellard ME, Bowden S, et al. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. J Infect. 2009;58(5):375-82.
13. Maher L, Chant K, Jalaludin BIN, et al. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia. J Gastroenterol Hepatol. 2004;19(10):1114-20. (Pubitemid 39371252)
14. Crofts N, Aitken CK. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust. 1997;167(1):17-20. (Pubitemid 27317522)
15. Crofts N, Stewart T, Hearne P, et al. Spread of bloodborne viruses among Australian prison entrants. Br Med J. 1995;310(6975):285-8.
16. World Health Organization. Expanded Programme on Immunization. Report of the 14th Global Advisory Group; 1991 October 14-18, Antalya, Turkey. Geneva (CHE): Global Advisory Group, WHO; 1992.
17. National Health and Medical Research Council Hepatitis B Working Party. Recommendations on Hepatitis B Immunisation. Canberra (AUST): Commonwealth Department of Health and Family Services; 1996.
18. National Health and Medical Research Council. The Australian Immunisation Handbook. 9th ed. Canberra (AUST): AGPS; 2008.
19. Gidding HF, Warlow M, MacIntyre CR, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007;25(51):8637-41. (Pubitemid 350199587)
20. Heron L, Selnikova O, Moiseieva A, et al. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: A randomised controlled trial. Vaccine. 2007;25(15):2817-22. (Pubitemid 46412571)
21. World Health Organization. Hepatitis B vaccines: WHO position paper - Recommendations. Vaccine. 2010;28(3):589-90.
22. Winstock A, Anderson C, Sheridan J. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Med J Aust. 2006;184:560-2. (Pubitemid 43950025)
23. Department of Health and Ageing. National Hepatitis B Strategy 2010-2013. Canberra (AUST): Commonwealth of Australia; 2010.
24. Macdonald V, Dore G, Amin J, et al. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007;4(1):27-30.
25. Rogers N, Lubman DI. An accelerated hepatitis B vaccination schedule for young drug users. Aust N Z J Public Health. 2005;29(4):305-7. (Pubitemid 41670828)
26. Mast E, Weinbaum C, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Morb Mortal Wkly Rep. 2006;55:1-40.
27. Maher L, White B, Donald A, et al. Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugs in community settings. Int J Drug Policy. 2010;21(3):194-201.
28. Biernacki P, Waldorf D. Snowball sampling: Problems, techniques and chain referral sampling. Sociol Methods Res. 1981;10:141-63.
29. Lum PJ, Hahn JA, Shafer KP, et al. Hepatitis B virus infection and immunization status in a new generation of injection drug users in San Francisco. J Viral Hepat. 2008;15(3):229-36. (Pubitemid 351143743)
30. Amesty S, Ompad D, Galea S, et al. Prevalence and Correlates of Previous Hepatitis B Vaccination and Infection Among Young Drug-users In New York City. J Community Health. 2008;33(3):139-48.
31. Baral S, Sherman S, Millson P, et al. Vaccine immunogenicity in injecting drug users: A systematic review. Lancet Infect Dis. 2007;7(10):667-74. (Pubitemid 47444565)
32. Quaglio G, Lugoboni F, Mezzelani P, et al. Hepatitis vaccination among drug users. Vaccine. 2006;24(15):2702-9.
33. Kuo I, Sherman SG, Thomas DL, et al. Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend. 2004;73(1):69-78. (Pubitemid 37542480)
34. Lum PJ, Ochoa KC, Hahn JA, et al. Hepatitis B Virus Immunization Among Young Injection Drug Users in San Francisco, Calif: The UFO Study. Am J Public Health. 2003;93(6):919-23. (Pubitemid 38480222)
35. McGregor J, Marks P, Hayward A, et al. Factors influencing hepatitis B vaccine uptake in injecting drug users. J Public Health Med. 2003;25:165-70. (Pubitemid 36758782)
36. Judd A, Hickman M, Hope VD, et al. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? J Viral Hepat. 2007;14(8):584-91. (Pubitemid 47075431)
37. Stitzer M, Polk T, Bowles S, et al. Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives. Drug Alcohol Depend. 2010;107(1):76-9.
38. Seal KH, Kral AH, Lorvick J, et al. A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol Depend. 2003;71(2):127-31. (Pubitemid 37289022)
39. Campbell JV, Garfein RS, Thiede H, et al. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users. Drug Alcohol Depend. 2007;91(1):S64-S72 (Pubitemid 47470019)
40. Des Jarlais DC, Fisher DG, Newman JC, et al. Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program. Am J Public Health. 2001;91(11):1791-2. (Pubitemid 33031733)
41. Altice F, Bruce R, Walton M, et al. Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health. 2005;82(1):151-61. (Pubitemid 41214137)
42. Yiqing H, Lauretta EG, Greg S, et al. Economic Evaluation of Delivering Hepatitis B Vaccine to Injection Drug Users. Am J Prev Med. 2008;35(1):25-32.
43. Lugoboni F, Migliozzi S, Schiesari F, et al. Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users. Vaccine. 1997;15(9):1014-6. (Pubitemid 27308579)
44. Wright NM, Campbell TL, Tompkins CN. Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users. Commun Dis Public Health. 2002;5(4):324-6.
45. Van Herck K, Leuridan E, Van Damme P. Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance. Sex Transm Infect. 2007;83(6):426-32. (Pubitemid 350063839)
46. Tawk H, Vickery K, Bisset L, et al. The current pattern of hepatitis B virus infection in Australia. J Viral Hepat. 2006;13:206-15.
47. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and selfreported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88:517-26.
48. De Irala J, Bigelow C, McCusker J, et al. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol. 1996;143:725-32. (Pubitemid 26108239)